2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide

C43H54N8O8 — CID 123473033

IUPAC2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide
SMILESCC1CC2C(=O)OC(C)C(NC(=O)C(Cc3ccccc3)NC(=O)Nc3ccc4ccn(C)c4c3)C(=O)N3CCCC3C(=O)N3CCCCC3C(=O)NC(C)C(=O)N2C1
InChIInChI=1S/C43H54N8O8/c1-25-21-35-42(57)59-27(3)36(41(56)50-19-10-14-33(50)40(55)49-18-9-8-13-32(49)38(53)44-26(2)39(54)51(35)24-25)47-37(52)31(22-28-11-6-5-7-12-28)46-43(58)45-30-16-15-29-17-20-48(4)34(29)23-30/h5-7,11-12,15-17,20,23,25-27,31-33,35-36H,8-10,13-14,18-19,21-22,24H2,1-4H3,(H,44,53)(H,47,52)(H2,45,46,58)
InChIKeyIILOIEQQTJJZMX-UHFFFAOYSA-N
MW810.95 g/mol
LogP2.45
Rot. Bonds6

About 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide

2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide (PubChem CID 123473033) has the molecular formula C43H54N8O8 and a molecular weight of 810.95 g/mol. Its IUPAC name is 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide.

Molecular Properties

Compound Name2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide
PubChem CID123473033
Molecular FormulaC43H54N8O8
Molecular Weight810.95 g/mol
Exact Mass810.41
IUPAC Name2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide
SMILESCC1CC2C(=O)OC(C)C(NC(=O)C(Cc3ccccc3)NC(=O)Nc3ccc4ccn(C)c4c3)C(=O)N3CCCC3C(=O)N3CCCCC3C(=O)NC(C)C(=O)N2C1
InChIInChI=1S/C43H54N8O8/c1-25-21-35-42(57)59-27(3)36(41(56)50-19-10-14-33(50)40(55)49-18-9-8-13-32(49)38(53)44-26(2)39(54)51(35)24-25)47-37(52)31(22-28-11-6-5-7-12-28)46-43(58)45-30-16-15-29-17-20-48(4)34(29)23-30/h5-7,11-12,15-17,20,23,25-27,31-33,35-36H,8-10,13-14,18-19,21-22,24H2,1-4H3,(H,44,53)(H,47,52)(H2,45,46,58)
InChIKeyIILOIEQQTJJZMX-UHFFFAOYSA-N
XLogP2.45
TPSA191.49 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms59
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500810.95
LogP ≤ 52.45
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Analyze 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide?
The IUPAC name of 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide (CID 123473033) is 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide.
What is the SMILES notation for 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide?
The canonical SMILES for 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide is CC1CC2C(=O)OC(C)C(NC(=O)C(Cc3ccccc3)NC(=O)Nc3ccc4ccn(C)c4c3)C(=O)N3CCCC3C(=O)N3CCCCC3C(=O)NC(C)C(=O)N2C1.
What is the InChIKey of 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide?
The InChIKey is IILOIEQQTJJZMX-UHFFFAOYSA-N. The full InChI is InChI=1S/C43H54N8O8/c1-25-21-35-42(57)59-27(3)36(41(56)50-19-10-14-33(50)40(55)49-18-9-8-13-32(49)38(53)44-26(2)39(54)51(35)24-25)47-37(52)31(22-28-11-6-5-7-12-28)46-43(58)45-30-16-15-29-17-20-48(4)34(29)23-30/h5-7,11-12,15-17,20,23,25-27,31-33,35-36H,8-10,13-14,18-19,21-22,24H2,1-4H3,(H,44,53)(H,47,52)(H2,45,46,58).
What are the key properties of 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide?
2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide has a molecular weight of 810.95 g/mol, XLogP of 2.45, 6 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(1-methylindol-6-yl)carbamoylamino]-3-phenyl-N-(10,15,19-trimethyl-2,8,12,18,21-pentaoxo-11-oxa-1,7,17,20-tetrazatetracyclo[20.4.0.03,7.013,17]hexacosan-9-yl)propanamide is sourced from PubChem (CID 123473033), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).